ArticleClinical kidney journal2021

Erratum to: Effect of linagliptin versus placebo on cardiovascular and kidney outcomes in nephrotic-range proteinuria and type 2 diabetes (t2d): the carmelina randomised controlled trial.

Christoph Wanner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.